Epstein Secrets

ody for covid-19. `We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and others, DARPA has quiet

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

rtunities and Vision for the Science and Technology Enterprise; with testimony from former Acting Deputy Secretary of Defense Christine Fox; former DARPA Director Dr Victoria Coleman; and American Enterprise Institute Resident Fellow Klon Kitchen * Held via WebEx and in Rm 2118, Rayburn House Office B

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and others, DARPA has quietl

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and others, DARPA has quietl

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake